Role of SGLT2 Inhibitors in Heart Failure Patients

Tejaswi Mekala, Veganti Sai Harsha, Vanukuri Madhupriya Reddy, Vardhineni Bhargavi, Mandava Mahima Swaroopa

Abstract: Objective: This study aims to assess the role of SGLT2 inhibitors in patients with heart failure. Methodology: This is a cross - sectional study performed at Pinnamaneni Siddhartha for 6 months to fill out the data collection forms of 120 patients with heart failure. The data was analyzed using the statistical software SPSS. Results: The study's results indicate that SGLT2 inhibitors played a vital role in reducing unfavorable outcomes. Conclusion: Our study compared risk factors with outcomes and concluded that risk factors have been a root cause of unfavorable outcomes. Depending on the study results, SGLT2 inhibitors effectively reduce unfavorable outcomes. Recommendations: Awareness programs to quit the use of tobacco and alcohol in society may help reduce the risk factors to some extent.

Keywords: Heart failure, SGLT2 inhibitors, Cardiovascular outcomes, Treatment decision making

How to Cite?: Tejaswi Mekala, Veganti Sai Harsha, Vanukuri Madhupriya Reddy, Vardhineni Bhargavi, Mandava Mahima Swaroopa, "Role of SGLT2 Inhibitors in Heart Failure Patients", Volume 12 Issue 12, December 2023, International Journal of Science and Research (IJSR), Pages: 413-415, https://www.ijsr.net/getabstract.php?paperid=MR231204180215, DOI: https://dx.doi.org/10.21275/MR231204180215